We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$441M
AUM Growth
-$197M
Cap. Flow
-$148M
Cap. Flow %
-33.49%
Top 10 Hldgs %
93.5%
Holding
67
New
13
Increased
16
Reduced
16
Closed
16

Top Buys

Rank Stock Value
1
BTG icon
B2Gold
BTG
+$103M
2
AQST icon
Aquestive Therapeutics
AQST
+$2.31M
3
QURE icon
uniQure
QURE
+$2.11M
4
SSTK icon
Shutterstock
SSTK
+$985K
5
HELP
Cybin Inc
HELP
+$619K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$211M
2
TDOC icon
Teladoc Health
TDOC
+$18.7M
3
INSW icon
International Seaways
INSW
+$10.1M
4
DOLE icon
Dole
DOLE
+$5.36M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$4.62M

Sector Composition

Rank Sector Weight
1 Materials 33.11%
2 Communication Services 30.69%
3 Consumer Staples 19.04%
4 Healthcare 6.31%
5 Energy 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MITT
26
TPG Mortgage Investment Trust
MITT
$222M
$340K 0.08%
51,202
-82,069
-62% -$581K
IOVA icon
27
Iovance Biotherapeutics
IOVA
$1.82B
$288K 0.07%
38,875
+1,500
+4% +$13.9K
PRAX icon
28
Praxis Precision Medicines
PRAX
$8.58B
$259K 0.06%
3,369
-63,915
-95% -$4.62M
VERV
29
DELISTED
Verve Therapeutics
VERV
$253K 0.06%
44,800
-800
-2% -$4.51K
ETNB
30
DELISTED
89bio
ETNB
$238K 0.05%
+30,439
New +$251K
CELC icon
31
Celcuity
CELC
$4.21B
$229K 0.05%
17,458
– –
IMTX icon
32
Immatics
IMTX
$1.18B
$224K 0.05%
31,462
+7,000
+29% +$60.1K
RZLT icon
33
Rezolute
RZLT
$454M
$212K 0.05%
43,187
+18,898
+78% +$95.2K
BHVN icon
34
Biohaven
BHVN
$2.03B
$205K 0.05%
5,496
– –
DAWN
35
DELISTED
Day One Biopharmaceuticals
DAWN
$203K 0.05%
+16,006
New +$223K
ADAM
36
Adamas Trust
ADAM
$815M
$165K 0.04%
27,301
-180,670
-87% -$1.06M
ACHV icon
37
Achieve Life Sciences
ACHV
$659M
$146K 0.03%
41,420
+8,301
+25% +$37.6K
URGN icon
38
UroGen Pharma
URGN
$1.86B
$133K 0.03%
+12,500
New +$150K
TCRX icon
39
TScan Therapeutics
TCRX
$48.6M
$133K 0.03%
43,723
– –
LRMR icon
40
Larimar Therapeutics
LRMR
$397M
$125K 0.03%
32,309
– –
INDV icon
41
Indivior Pharmaceuticals
INDV
$4.73B
$124K 0.03%
+10,001
New +$103K
LXEO icon
42
Lexeo Therapeutics
LXEO
$324M
$106K 0.02%
+16,100
New +$127K
NUVB icon
43
Nuvation Bio
NUVB
$2.2B
$104K 0.02%
+39,000
New +$100K
ENGN icon
44
enGene Therapeutics
ENGN
$120M
$97.8K 0.02%
+14,710
New +$114K
ACRV icon
45
Acrivon Therapeutics
ACRV
$64.2M
$91.7K 0.02%
+15,235
New +$111K
RGNX icon
46
Regenxbio
RGNX
$620M
$90.6K 0.02%
+11,721
New +$110K
CMCT
47
Creative Media & Community Trust
CMCT
$10.3M
$89.3K 0.02%
16
-3
-16% -$27K
SGMT icon
48
Sagimet Biosciences
SGMT
$439M
$82.4K 0.02%
+18,310
New +$92.8K
ASPI icon
49
ASP Isotopes
ASPI
$504M
$53K 0.01%
+11,700
New +$62.3K
NEWP
50
New Pacific Metals
NEWP
$859M
$49.7K 0.01%
42,130
+8,600
+26% +$13.4K
1
2
3

Similar funds

WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return

Pale Fire Capital SE's Q4 2024 Portfolio in Review

As of Q4 2024, Pale Fire Capital SE held 67 positions worth $441M, down 31% from $638M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Pale Fire Capital SE withdrew a net $148M in Q4 2024, closing 16 positions and reducing 16 holdings. Its most notable exit was AT&T, an estimated $211M position sold in full.

By sector, the portfolio is most concentrated in Materials at 33% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Pale Fire Capital SE opened a new position in Cybin Inc worth $537K.

  • Pale Fire Capital SE's largest Q4 2024 buy was Cybin Inc: 60,912 shares worth $537K.
  • Pale Fire Capital SE added most to B2Gold in Q4 2024, an estimated $103M increase.
  • Pale Fire Capital SE's biggest Q4 2024 reduction was Teladoc Health, cutting an estimated $18.7M.
  • Pale Fire Capital SE fully exited AT&T in Q4 2024, selling an estimated $211M.
  • Pale Fire Capital SE's ten largest holdings make up 93% of its $441M portfolio in Q4 2024.
  • Pale Fire Capital SE opened 13 new positions and closed 16 in Q4 2024.
  • Pale Fire Capital SE's portfolio value fell 31% quarter-over-quarter to $441M.

Based on Pale Fire Capital SE's 13F filing for Q4 2024, filed 13 Feb 2025.